Targeting Sphingosine Kinase 1 in Acute Myeloid Leukemia: Translation to Clinic
International Journal of Hematologic Oncology · 2017
DOI: 10.2217/ijh-2017-0011 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Hematologic Oncology, 2017. Verfasst von Jason A Powell und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Biology, University of South Australia & SA Pathology, Adelaide, Australia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Peter Doherty Biomedical Early Career Fellowship, CT Wallington-Beddoe, and a Senior Research Fellowship.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Cancer Biology, University of South Australia & SA Pathology, Adelaide, Australia.
- School of Medicine, University of Adelaide, Adelaide, Australia.
- School of Medicine, Flinders University, Adelaide, Australia.
Förderung
- Peter Doherty Biomedical Early Career Fellowship
- CT Wallington-Beddoe, and a Senior Research Fellowship
Zitieren
APA
Powell, J. A., Wallington-Beddoe, C. T., & Pitson, S. M. (2017). Targeting Sphingosine Kinase 1 in Acute Myeloid Leukemia: Translation to Clinic. International Journal of Hematologic Oncology. https://doi.org/10.2217/ijh-2017-0011
Vancouver
Powell JA, Wallington-Beddoe CT, Pitson SM. Targeting Sphingosine Kinase 1 in Acute Myeloid Leukemia: Translation to Clinic. International Journal of Hematologic Oncology. 2017. doi:10.2217/ijh-2017-0011
BibTeX
@article{Powell2017,
author = {Powell, Jason A and Wallington-Beddoe, Craig T and Pitson, Stuart M},
title = {Targeting Sphingosine Kinase 1 in Acute Myeloid Leukemia: Translation to Clinic},
journal = {International Journal of Hematologic Oncology},
year = {2017},
doi = {10.2217/ijh-2017-0011}
}
EUVIMED